BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 3674773)

  • 1. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early oral contraceptive use as a prognostic factor in breast cancer.
    Olsson H; Möller TR; Ranstam J; Borg A; Fernö M
    Anticancer Res; 1988; 8(1):29-32. PubMed ID: 3358638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A biological marker, strongly associated with early oral contraceptive use, for the selection of a high risk group for premenopausal breast cancer.
    Olsson H; Borg A; Ewers SB; Fernö M; Möller T; Ranstam J
    Med Oncol Tumor Pharmacother; 1986; 3(2):77-81. PubMed ID: 3747639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraception and breast pathology.
    Ragni N; Boccardo E; Viglino S; Larosa E
    Acta Eur Fertil; 1981 Jun; 12(2):141-63. PubMed ID: 6794288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival in breast cancer and age at start of oral contraceptive usage.
    Ranstam J; Olsson H; Garne JP; Aspegren K; Janzon L
    Anticancer Res; 1991; 11(6):2043-6. PubMed ID: 1776838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
    Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
    Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of teenage oral contraceptive use in a population-based series of early-onset breast cancer cases who have undergone BRCA mutation testing.
    Jernström H; Loman N; Johannsson OT; Borg A; Olsson H
    Eur J Cancer; 2005 Oct; 41(15):2312-20. PubMed ID: 16118051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral contraceptives and breast cancer.
    Gay JW; Cardwell MS
    Mo Med; 1990 Oct; 87(10):763-7. PubMed ID: 2259330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Researchers can now investigate long-term effects of OCs on cancer.
    Rubin GL; Peterson HB
    Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pill and the breast.
    Drife JO
    IPPF Med Bull; 1984 Dec; 18(6):1-2. PubMed ID: 12313402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of oral contraceptives and the risk of breast cancer.
    Webster L
    J Reprod Med; 1986 Jun; 31(6 Suppl):540-5. PubMed ID: 3723486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early oral contraceptive use and premenopausal breast cancer--a review of studies performed in southern Sweden.
    Olsson H; Borg A; Fernö M; Möller TR; Ranstam J
    Cancer Detect Prev; 1991; 15(4):265-71. PubMed ID: 1794133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The contraceptive pill and cancer].
    Lancet M
    Harefuah; 1990 Dec; 119(12):432-7. PubMed ID: 2074068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers.
    McTiernan A; Thomas DB; Johnson LK; Roseman D
    J Natl Cancer Inst; 1986 Oct; 77(4):849-54. PubMed ID: 3463818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review: oral contraceptives and menopausal estrogens in relation to breast neoplasia.
    Brzezinski A; Schenker JG
    Isr J Med Sci; 1982 Apr; 18(4):433-8. PubMed ID: 7045033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contraception without risk of breast disease: epidemiologic and physiopathologic arguments].
    Le Coutour X
    NPN Med; 1985 Apr; 5(88):471-6. PubMed ID: 12315304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IPPF statement on oral contraceptives and cancer of the breast.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1989 Apr; 23(2):4. PubMed ID: 12342374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.